Adaptimmune Therapeutics shares owned by Two Sigma Advisers
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Two Sigma Advisers
from 13F filings
Historical chart of Two Sigma Advisers investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Two Sigma Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $3.2k | 13k | 0.24 |
| 2025-03-31 | $41k | 207k | 0.20 |
| 2024-12-31 | $38k | 71k | 0.54 |
| 2024-09-30 | $11k | 12k | 0.95 |
| 2024-06-30 | $33k | 33k | 0.97 |
| 2024-03-31 | $73k | 46k | 1.58 |
| 2023-12-31 | $48k | 60k | 0.79 |
| 2023-09-30 | $50k | 64k | 0.78 |
| 2023-06-30 | $90k | 97k | 0.93 |
| 2023-03-31 | $37k | 34k | 1.09 |
| 2022-12-31 | $44k | 30k | 1.46 |
| 2022-09-30 | $33k | 31k | 1.06 |
| 2022-06-30 | $60k | 35k | 1.70 |
| 2022-03-31 | $216k | 105k | 2.06 |